4 research departments
750 employees
45 nationalities
55 research teams
16 ERC laureates
260 publications per year
24000 m² lab area

Support us through

Fondation universite de Strasbourg



Izabela SUMARA
Tel. : +33 (0)3 88 65 33 88
Tel. : +33 (0)3 88 65 35 21

Key figures

52 research teams
138 researchers
48 post-doctoral fellows
93 PhD students
133 engineers & technicians
117 administrators & general services 110 ICS employees

Quick Links

Job opportunities

Linking Ubiquitin Signaling To Fragile X Syndrome (Fxs)

Reference : PhD Izabela Sumara

Offer publication : Jan. 26, 2018

Fragile X syndrome (FXS) is the most common form of cognitive human disability, for which no efficient therapy exists to date. It is caused by silencing of Fragile X mental retardation protein FMRP, which belongs to the Fragile X-related (FXR) protein family together with FXR1 and FXR2. These proteins are RNA binding proteins that critically control translational processes of hundreds of transcripts. However, their roles beyond RNA regulation remain elusive.


We found an unexpected link between FXR proteins and nuclear organization and showed that they regulate assembly of nucleoporins (NUPs) at the nuclear envelope (NE). We further identified the ubiquitin binding protein NICE-4 as a specific partner of FXR proteins that controls their localization to NE. Thus, we have identified the first regulatory factor of the FXR-NUP pathway that links it to ubiquitin signaling. We hypothesize that its misregulation will change differentiation programs and contribute to the pathology of FXS and related human disorders.


The aim of this project is to characterize the role of ubiquitin signaling in Fragile X syndrome and related diseases.

Your application

Application Deadline : Nov. 1, 2018

Imprimer Envoyer

Université de Strasbourg

IGBMC - CNRS UMR 7104 - Inserm U 1258
1 rue Laurent Fries / BP 10142 / 67404 Illkirch CEDEX / France Tél +33 (0)3 88 65 32 00 / Fax +33 (0)3 88 65 32 01 / directeur.igbmc@igbmc.fr